HENNION & WALSH ASSET MANAGEMENT, INC. – Karyopharm Therapeutics Inc. Transaction History
HENNION & WALSH ASSET MANAGEMENT, INC. portfolio value:
$1.50M
portfolio value
HENNION & WALSH ASSET MANAGEMENT, INC. quarter portfolio value change:
+21.06%
quarter
Karyopharm Therapeutics Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -3.57% | -10.23K shares | 216K | $5.46 | 276.42K |
| Q2 2022 | share | Decrease | -25.70% | -99.17K shares | -1.55M | $4.51 | 286.65K |
| Q1 2022 | share | Decrease | -2.00% | -7.85K shares | 313K | $7.37 | 385.83K |
| Q4 2021 | share | Decrease | -3.38% | -13.78K shares | 160K | $6.72 | 393.69K |
| Q3 2021 | share | Increase | +8.43% | 31.67K shares | -1.50M | $5.82 | 407.47K |
| Q2 2021 | share | Increase | +40.77% | 108.83K shares | 1.06M | $10.32 | 375.79K |
| Q1 2021 | share | Increase | 0.00% | 266.96K shares | 2.80M | $10.52 | 266.96K |